|
G |
Acadm |
acyl-Coenzyme A dehydrogenase, medium chain |
increases expression |
EXP |
Homocysteine results in increased expression of ACADM mRNA; Homocysteine results in increased expression of ACADM protein |
CTD |
PMID:26993217 |
|
NCBI chr 3:153,627,990...153,650,280
Ensembl chr 3:153,627,994...153,650,269
|
|
G |
Ache |
acetylcholinesterase |
increases activity |
ISO |
Homocysteine results in increased activity of ACHE protein |
CTD |
PMID:16375580 |
|
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
|
|
G |
Acta2 |
actin alpha 2, smooth muscle, aorta |
multiple interactions increases expression |
EXP |
[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of ACTA2 mRNA; [Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of ACTA2 protein; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of ACTA2 mRNA]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of ACTA2 protein] Homocysteine results in increased expression of ACTA2 mRNA; Homocysteine results in increased expression of ACTA2 protein |
CTD |
PMID:21647593 |
|
NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
|
|
G |
Ahcy |
S-adenosylhomocysteine hydrolase |
multiple interactions |
ISO |
[Arsenic results in increased expression of and results in increased activity of AHCY protein] which results in increased chemical synthesis of Homocysteine |
CTD |
PMID:18487201 |
|
NCBI chr 2:154,901,230...154,916,417
Ensembl chr 2:154,901,230...154,916,417
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
multiple interactions decreases phosphorylation |
EXP |
Atorvastatin inhibits the reaction [Homocysteine results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:20305681 |
|
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Alb |
albumin |
multiple interactions |
ISO |
Folic Acid inhibits the reaction [Homocysteine inhibits the reaction [ALB protein binds to Bilirubin]]; Homocysteine inhibits the reaction [ALB protein binds to Bilirubin] |
CTD |
PMID:33788065 |
|
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
|
|
G |
Apoa1 |
apolipoprotein A-I |
decreases expression multiple interactions |
ISO |
Homocysteine results in decreased expression of APOA1 mRNA; Homocysteine results in decreased expression of APOA1 protein Homocysteine inhibits the reaction [Simvastatin results in increased expression of APOA1 mRNA]; Homocysteine inhibits the reaction [Simvastatin results in increased expression of APOA1 protein] |
CTD |
PMID:18540024 |
|
NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
|
|
G |
App |
amyloid beta precursor protein |
increases abundance |
EXP |
APP protein results in increased abundance of Homocysteine |
CTD |
PMID:16837103 |
|
NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
|
|
G |
Atf1 |
activating transcription factor 1 |
multiple interactions |
ISO |
Homocysteine promotes the reaction [ATF1 protein binds to CCNA2 promoter] |
CTD |
PMID:8550827 |
|
NCBI chr15:100,125,729...100,159,129
Ensembl chr15:100,125,700...100,159,125
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions affects localization affects expression increases expression |
ISO |
BAX protein inhibits the reaction [Cystathionine inhibits the reaction [Homocysteine results in increased activity of CASP3 protein]]; BTSA1 compound inhibits the reaction [Cystathionine inhibits the reaction [Homocysteine affects the localization of BAX protein]]; Cystathionine inhibits the reaction [Homocysteine affects the localization of BAX protein]; Cystathionine inhibits the reaction [Homocysteine results in increased expression of and affects the localization of BAX protein]; Folic Acid affects the reaction [Homocysteine affects the expression of BAX mRNA]; Folic Acid affects the reaction [Homocysteine affects the expression of BAX protein]; Homocysteine results in increased expression of and affects the localization of BAX protein; Zeranol inhibits the reaction [Homocysteine results in increased expression of BAX protein] Homocysteine affects the expression of BAX mRNA; Homocysteine affects the expression of BAX protein Folic Acid inhibits the reaction [Homocysteine results in increased expression of BAX mRNA] |
CTD |
PMID:16757814 PMID:29250709 PMID:31721048 PMID:31885769 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bche |
butyrylcholinesterase |
multiple interactions decreases activity |
ISO |
Folic Acid inhibits the reaction [Homocysteine results in decreased activity of BCHE protein] |
CTD |
PMID:16442260 |
|
NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions affects expression decreases expression |
ISO |
Folic Acid affects the reaction [Homocysteine affects the expression of BCL2 mRNA]; Folic Acid affects the reaction [Homocysteine affects the expression of BCL2 protein]; Zeranol inhibits the reaction [Homocysteine results in decreased expression of BCL2 protein] Homocysteine affects the expression of BCL2 mRNA; Homocysteine affects the expression of BCL2 protein [Homocysteine co-treated with Sodium Glutamate] affects the expression of BCL2 mRNA; [Homocysteine co-treated with Sodium Glutamate] affects the expression of BCL2 protein; Folic Acid affects the reaction [[Homocysteine co-treated with Sodium Glutamate] affects the expression of BCL2 mRNA]; Folic Acid affects the reaction [[Homocysteine co-treated with Sodium Glutamate] affects the expression of BCL2 protein] |
CTD |
PMID:16757814 PMID:22169520 PMID:29250709 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
decreases expression multiple interactions |
ISO |
Homocysteine results in decreased expression of BIRC2 mRNA; Homocysteine results in decreased expression of BIRC2 protein Simvastatin inhibits the reaction [Homocysteine results in decreased expression of BIRC2 mRNA]; Simvastatin inhibits the reaction [Homocysteine results in decreased expression of BIRC2 protein] |
CTD |
PMID:19343037 |
|
NCBI chr 9:7,818,227...7,837,123
Ensembl chr 9:7,818,228...7,837,065
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
decreases expression multiple interactions |
ISO |
Homocysteine results in decreased expression of BIRC3 mRNA; Homocysteine results in decreased expression of BIRC3 protein Simvastatin inhibits the reaction [Homocysteine results in decreased expression of BIRC3 mRNA]; Simvastatin inhibits the reaction [Homocysteine results in decreased expression of BIRC3 protein] |
CTD |
PMID:19343037 |
|
NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187
|
|
G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
affects binding |
ISO |
Homocysteine analog binds to CACNA2D1 protein |
CTD |
PMID:16380257 |
|
NCBI chr 5:16,139,390...16,579,509
Ensembl chr 5:16,139,786...16,579,502
|
|
G |
Calr |
calreticulin |
increases expression |
EXP |
Homocysteine results in increased expression of CALR mRNA |
CTD |
PMID:26993217 |
|
NCBI chr 8:85,568,717...85,573,560
Ensembl chr 8:85,568,479...85,573,563
|
|
G |
Casp1 |
caspase 1 |
multiple interactions increases activity increases expression |
EXP |
[Folic Acid deficiency results in increased abundance of Homocysteine] promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]; CASP1 protein affects the reaction [Homocysteine promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]]; CASP1 protein affects the reaction [Homocysteine results in decreased secretion of VEGFA protein]; Homocysteine promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]; PYCARD protein affects the reaction [Homocysteine promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]]; PYCARD protein affects the reaction [Homocysteine results in increased activity of CASP1 protein] Homocysteine results in increased expression of CASP1 mRNA |
CTD |
PMID:22647887 |
|
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
|
|
G |
Casp3 |
caspase 3 |
multiple interactions affects cleavage increases expression affects expression increases activity |
ISO EXP |
BAX protein inhibits the reaction [Cystathionine inhibits the reaction [Homocysteine results in increased activity of CASP3 protein]]; BTSA1 compound inhibits the reaction [Cystathionine inhibits the reaction [Homocysteine results in increased cleavage of CASP3 protein]]; Cystathionine inhibits the reaction [Homocysteine results in increased activity of and results in increased cleavage of CASP3 protein]; Folic Acid affects the reaction [Homocysteine affects the cleavage of CASP3 protein]; Folic Acid affects the reaction [Homocysteine affects the expression of CASP3 mRNA]; Homocysteine results in increased activity of and results in increased cleavage of CASP3 protein; mecobalamin inhibits the reaction [Homocysteine results in increased activity of CASP3 protein]; Simvastatin inhibits the reaction [Homocysteine results in increased activity of CASP3 protein] Folic Acid inhibits the reaction [Homocysteine results in increased expression of CASP3 protein] Atorvastatin inhibits the reaction [Homocysteine results in increased activity of CASP3 protein] Homocysteine results in increased expression of CASP3 mRNA; Homocysteine results in increased expression of CASP3 protein |
CTD |
PMID:16715183 PMID:19343037 PMID:20305681 PMID:21237187 PMID:29250709 PMID:31721048 PMID:31885769 More...
|
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp7 |
caspase 7 |
increases activity multiple interactions |
ISO |
Homocysteine results in increased activity of CASP7 protein mecobalamin inhibits the reaction [Homocysteine results in increased activity of CASP7 protein] |
CTD |
PMID:21237187 |
|
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
|
|
G |
Casp8 |
caspase 8 |
multiple interactions affects expression |
ISO |
Folic Acid affects the reaction [Homocysteine affects the expression of CASP8 mRNA]; Folic Acid affects the reaction [Homocysteine affects the expression of CASP8 protein] Homocysteine affects the expression of CASP8 mRNA; Homocysteine affects the expression of CASP8 protein |
CTD |
PMID:29250709 |
|
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Casp9 |
caspase 9 |
increases activity multiple interactions |
ISO |
Homocysteine results in increased activity of CASP9 protein BTSA1 compound inhibits the reaction [Cystathionine inhibits the reaction [Homocysteine results in increased activity of CASP9 protein]]; Cystathionine inhibits the reaction [Homocysteine results in increased activity of CASP9 protein] |
CTD |
PMID:31885769 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Cat |
catalase |
decreases transport multiple interactions decreases expression |
ISO |
CAT protein results in decreased transport of Homocysteine [CAT gene SNP results in increased susceptibility to [Air Pollutants results in increased abundance of Particulate Matter]] which results in increased abundance of Homocysteine Homocysteine results in decreased expression of CAT protein |
CTD |
PMID:12631446 PMID:22964297 PMID:30477822 |
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Cbs |
cystathionine beta-synthase |
affects abundance multiple interactions |
EXP ISO |
CBS protein affects the abundance of Homocysteine; CBS protein affects the abundance of Homocysteine metabolite Homocysteine inhibits the reaction [Folic Acid results in increased activity of CBS protein] |
CTD |
PMID:19204075 PMID:23024785 PMID:31721048 |
|
NCBI chr17:31,831,602...31,856,170
Ensembl chr17:31,827,868...31,856,212
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions increases expression |
ISO |
[Homocysteine results in increased expression of CCL2 protein] which results in increased phosphorylation of NFKBIA protein; [Homocysteine results in increased expression of CCL2 protein] which results in increased reduction of NFKBIA mRNA; acetovanillone inhibits the reaction [Homocysteine results in increased expression of CCL2 mRNA]; Folic Acid inhibits the reaction [Homocysteine results in increased expression of CCL2 mRNA] Homocysteine results in increased expression of CCL2 mRNA; Homocysteine results in increased expression of CCL2 protein |
CTD |
PMID:11356643 PMID:16845898 |
|
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions increases expression |
ISO |
[Homocysteine co-treated with Lipopolysaccharides] results in increased secretion of CCL5 protein Homocysteine results in increased expression of CCL5 mRNA |
CTD |
PMID:16225753 |
|
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
|
|
G |
Ccn4 |
cellular communication network factor 4 |
decreases expression |
ISO |
Homocysteine results in decreased expression of CCN4 mRNA |
CTD |
PMID:17320366 |
|
NCBI chr15:66,763,337...66,795,050
Ensembl chr15:66,763,169...66,795,050
|
|
G |
Ccna1 |
cyclin A1 |
multiple interactions decreases methylation decreases expression |
ISO |
DNMT1 protein affects the reaction [Homocysteine results in decreased expression of CCNA1 mRNA]; Homocysteine inhibits the reaction [MECP2 protein binds to CCNA1 promoter]; Homocysteine promotes the reaction [H3-4 protein modified form binds to CCNA1 promoter]; Homocysteine promotes the reaction [H4C16 protein modified form binds to CCNA1 promoter] Homocysteine results in decreased methylation of CCNA1 promoter |
CTD |
PMID:17698632 |
|
NCBI chr 3:54,952,890...54,965,055
Ensembl chr 3:54,952,890...54,962,922
|
|
G |
Ccna2 |
cyclin A2 |
multiple interactions increases expression |
ISO |
Dactinomycin inhibits the reaction [Homocysteine results in increased expression of CCNA2 mRNA]; Homocysteine promotes the reaction [ATF1 protein binds to CCNA2 promoter] Homocysteine results in increased expression of CCNA2 mRNA; Homocysteine results in increased expression of CCNA2 protein |
CTD |
PMID:8550827 |
|
NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
|
|
G |
Cdh3 |
cadherin 3 |
multiple interactions decreases expression |
EXP |
[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of CDH3 mRNA; [Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of CDH3 protein; acetovanillone inhibits the reaction [Homocysteine results in decreased expression of CDH3 protein]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of CDH3 mRNA]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of CDH3 protein]; CYBB mutant form inhibits the reaction [Homocysteine results in decreased expression of CDH3 protein] Homocysteine results in decreased expression of CDH3 mRNA; Homocysteine results in decreased expression of CDH3 protein |
CTD |
PMID:21647593 |
|
NCBI chr 8:107,237,484...107,283,543
Ensembl chr 8:107,237,523...107,283,929
|
|
G |
Comt |
catechol-O-methyltransferase |
multiple interactions |
ISO |
[tolcapone results in decreased activity of COMT protein] inhibits the reaction [Levodopa results in increased abundance of Homocysteine] |
CTD |
PMID:16758261 |
|
NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602
|
|
G |
Cox5b |
cytochrome c oxidase subunit 5B |
multiple interactions |
ISO |
[Methionine deficiency co-treated with Homocysteine] affects the expression of COX5B protein |
CTD |
PMID:17116298 |
|
NCBI chr 1:36,730,568...36,732,469
Ensembl chr 1:36,730,530...36,732,762
|
|
G |
Crk |
v-crk avian sarcoma virus CT10 oncogene homolog |
multiple interactions |
ISO |
[Methionine deficiency co-treated with Homocysteine] affects the expression of CRK protein |
CTD |
PMID:17116298 |
|
NCBI chr11:75,570,020...75,599,254
Ensembl chr11:75,570,085...75,597,734
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
increases expression multiple interactions increases secretion |
ISO |
Homocysteine results in increased expression of CXCL8 mRNA; Homocysteine results in increased expression of CXCL8 protein [Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; [Adenosine co-treated with Homocysteine] results in decreased expression of CXCL8 mRNA; Ascorbic Acid affects the reaction [Homocysteine results in increased secretion of CXCL8 protein]; Copper Sulfate promotes the reaction [Homocysteine results in increased expression of CXCL8 mRNA]; Vitamin E affects the reaction [Homocysteine results in increased secretion of CXCL8 protein] |
CTD |
PMID:12964812 PMID:16715183 PMID:24224954 |
|
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Cybb |
cytochrome b-245, beta polypeptide |
multiple interactions increases expression affects localization |
EXP |
CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of CDH3 mRNA]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of CDH3 protein]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of TJP1 mRNA]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of ACTA2 mRNA]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of ACTA2 protein]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of S100A4 mRNA]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of S100A4 protein]; CYBB mutant form inhibits the reaction [Homocysteine results in decreased expression of CDH3 protein]; CYBB mutant form inhibits the reaction [Homocysteine results in decreased expression of TJP1 protein]; CYBB mutant form inhibits the reaction [Homocysteine results in increased abundance of Superoxides]; CYBB mutant form inhibits the reaction [Homocysteine results in increased expression of S100A4 protein]; CYBB protein affects the reaction [Homocysteine results in decreased secretion of VEGFA protein]; CYBB protein affects the reaction [Homocysteine results in increased abundance of Superoxides]; CYBB protein mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of NPHS1 mRNA]; CYBB protein mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of NPHS2 mRNA]; CYBB protein mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of DES mRNA]; Filipin inhibits the reaction [Homocysteine affects the localization of CYBB protein]; methyl-beta-cyclodextrin inhibits the reaction [Homocysteine affects the localization of CYBB protein] Homocysteine results in increased expression of CYBB mRNA; Homocysteine results in increased expression of CYBB protein |
CTD |
PMID:20036696 PMID:20116427 PMID:21647593 |
|
NCBI chr X:9,301,493...9,354,005
Ensembl chr X:9,301,491...9,354,010
|
|
G |
Ddc |
dopa decarboxylase |
multiple interactions |
ISO |
[Levodopa co-treated with DDC] results in decreased abundance of Homocysteine |
CTD |
PMID:11445284 |
|
NCBI chr11:11,764,101...11,848,144
Ensembl chr11:11,764,101...11,848,144
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions increases expression |
ISO |
Glycine inhibits the reaction [Homocysteine results in increased expression of DDIT3 mRNA]; Glycine inhibits the reaction [Homocysteine results in increased expression of DDIT3 protein] Homocysteine results in increased expression of DDIT3 mRNA; Homocysteine results in increased expression of DDIT3 protein |
CTD |
PMID:27064126 |
|
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
|
|
G |
Des |
desmin |
multiple interactions increases expression |
EXP |
[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of DES mRNA; acetovanillone inhibits the reaction [Homocysteine results in increased expression of DES mRNA]; acetovanillone inhibits the reaction [Homocysteine results in increased expression of DES protein]; Amitriptyline inhibits the reaction [Homocysteine results in increased expression of DES protein]; CYBB protein mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of DES mRNA]; diphenyleneiodonium inhibits the reaction [Homocysteine results in increased expression of DES mRNA]; diphenyleneiodonium inhibits the reaction [Homocysteine results in increased expression of DES protein]; Filipin inhibits the reaction [Homocysteine results in increased expression of DES mRNA]; Filipin inhibits the reaction [Homocysteine results in increased expression of DES protein]; methyl-beta-cyclodextrin inhibits the reaction [Homocysteine results in increased expression of DES mRNA]; methyl-beta-cyclodextrin inhibits the reaction [Homocysteine results in increased expression of DES protein] Homocysteine results in increased expression of DES mRNA; Homocysteine results in increased expression of DES protein |
CTD |
PMID:20036696 PMID:20116427 PMID:23024785 |
|
NCBI chr 1:75,336,936...75,345,223
Ensembl chr 1:75,336,973...75,345,223
|
|
G |
Dnm1l |
dynamin 1-like |
multiple interactions |
ISO |
Homocysteine results in increased expression of and results in increased phosphorylation of DNM1L protein; xestospongin C inhibits the reaction [Homocysteine results in increased expression of and results in increased phosphorylation of DNM1L protein] |
CTD |
PMID:33751715 |
|
NCBI chr16:16,130,092...16,176,863
Ensembl chr16:16,130,094...16,176,823
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
decreases activity multiple interactions |
ISO |
Homocysteine results in decreased activity of DNMT1 protein DNMT1 protein affects the reaction [Homocysteine results in decreased expression of CCNA1 mRNA] |
CTD |
PMID:17698632 |
|
NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions affects expression |
ISO |
Zeranol inhibits the reaction [Homocysteine affects the expression of EDN1 protein] |
CTD |
PMID:16757814 |
|
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
decreases phosphorylation |
ISO |
Homocysteine results in decreased phosphorylation of EIF2AK3 protein |
CTD |
PMID:22964297 |
|
NCBI chr 6:70,821,468...70,882,225
Ensembl chr 6:70,821,499...70,882,229
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
increases phosphorylation |
ISO |
Homocysteine results in increased phosphorylation of EIF2S1 protein |
CTD |
PMID:22964297 |
|
NCBI chr12:78,908,846...78,933,784
Ensembl chr12:78,908,593...78,933,784
|
|
G |
Ephb6 |
Eph receptor B6 |
decreases expression |
ISO |
Homocysteine results in decreased expression of EPHB6 mRNA |
CTD |
PMID:17320366 |
|
NCBI chr 6:41,581,940...41,597,445
Ensembl chr 6:41,582,416...41,597,443
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signalling 1 |
decreases phosphorylation |
ISO |
Homocysteine results in decreased phosphorylation of ERN1 protein |
CTD |
PMID:22964297 |
|
NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678
|
|
G |
Ero1a |
endoplasmic reticulum oxidoreductase 1 alpha |
decreases expression |
ISO |
Homocysteine results in decreased expression of ERO1A protein |
CTD |
PMID:22964297 |
|
NCBI chr14:45,520,544...45,556,029
Ensembl chr14:45,520,544...45,556,228
|
|
G |
Exosc4 |
exosome component 4 |
multiple interactions |
ISO |
[Methionine deficiency co-treated with Homocysteine] affects the expression of EXOSC4 protein |
CTD |
PMID:17116298 |
|
NCBI chr15:76,211,597...76,214,870
Ensembl chr15:76,211,597...76,214,877
|
|
G |
Gata4 |
GATA binding protein 4 |
decreases expression multiple interactions |
ISO |
Homocysteine results in decreased expression of GATA4 mRNA; Homocysteine results in decreased expression of GATA4 protein Particulate Matter promotes the reaction [Homocysteine results in decreased expression of GATA4 protein] |
CTD |
PMID:27203204 |
|
NCBI chr14:63,436,363...63,509,161
Ensembl chr14:63,436,371...63,509,141
|
|
G |
Gh |
growth hormone |
decreases abundance |
ISO |
GH1 protein results in decreased abundance of Homocysteine |
CTD |
PMID:17311540 PMID:17324600 |
|
NCBI chr11:106,191,087...106,194,529
Ensembl chr11:106,191,097...106,192,691
|
|
G |
Gpt |
glutamic pyruvic transaminase, soluble |
increases activity multiple interactions |
ISO |
Homocysteine results in increased activity of GPT protein Folic Acid inhibits the reaction [Homocysteine results in increased activity of GPT protein] |
CTD |
PMID:33788065 |
|
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
decreases activity decreases expression |
ISO |
Homocysteine results in decreased activity of GPX1 protein Homocysteine results in decreased expression of GPX1 protein |
CTD |
PMID:15734734 |
|
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
|
|
G |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
increases expression |
ISO |
Homocysteine analog results in increased expression of GRIN1 protein |
CTD |
PMID:20406136 |
|
NCBI chr 2:25,181,189...25,209,199
Ensembl chr 2:25,181,193...25,209,199
|
|
G |
Gsr |
glutathione reductase |
decreases expression |
ISO |
Homocysteine results in decreased expression of GSR protein |
CTD |
PMID:22964297 |
|
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
multiple interactions |
ISO |
[Methionine deficiency co-treated with Homocysteine] affects the expression of GSTM3 protein |
CTD |
PMID:17116298 |
|
NCBI chr 3:107,803,240...107,806,002
Ensembl chr 3:107,803,137...107,806,002
|
|
G |
Gstp1 |
glutathione S-transferase, pi 1 |
multiple interactions |
ISO |
[GSTP1 gene SNP results in increased susceptibility to [Air Pollutants results in increased abundance of Particulate Matter]] which results in increased abundance of Homocysteine |
CTD |
PMID:30477822 |
|
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
|
|
G |
H3f4 |
H3.4 histone, cluster member |
multiple interactions |
ISO |
Homocysteine promotes the reaction [H3-4 protein modified form binds to CCNA1 promoter] |
CTD |
PMID:17698632 |
|
NCBI chr11:58,852,537...58,853,099
Ensembl chr11:58,852,599...58,853,364
|
|
G |
H4c16 |
H4 histone 16 |
multiple interactions |
ISO |
Homocysteine promotes the reaction [H4C16 protein modified form binds to CCNA1 promoter] |
CTD |
PMID:17698632 |
|
NCBI chr 6:136,780,991...136,781,429
Ensembl chr 6:136,778,551...136,781,413
|
|
G |
Hspa5 |
heat shock protein 5 |
multiple interactions increases expression |
ISO |
Glycine inhibits the reaction [Homocysteine results in increased expression of HSPA5 mRNA] Homocysteine results in increased expression of HSPA5 mRNA; Homocysteine results in increased expression of HSPA5 protein |
CTD |
PMID:19960509 PMID:27064126 |
|
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
|
|
G |
Hspa9 |
heat shock protein 9 |
multiple interactions |
ISO |
Homocysteine promotes the reaction [HSPA9 protein binds to ITPR1 protein]; Homocysteine promotes the reaction [HSPA9 protein binds to VDAC1 protein] |
CTD |
PMID:33751715 |
|
NCBI chr18:35,070,467...35,087,404
Ensembl chr18:35,070,467...35,087,410
|
|
G |
Ins1 |
insulin I |
multiple interactions |
ISO |
[Alloxan co-treated with Homocysteine] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Homocysteine inhibits the reaction [Glucose results in increased secretion of INS1 protein] |
CTD |
PMID:27317948 |
|
NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
|
|
G |
Isl1 |
ISL1 transcription factor, LIM/homeodomain |
affects expression multiple interactions |
EXP |
Homocysteine affects the expression of ISL1 mRNA Folic Acid inhibits the reaction [Homocysteine affects the expression of ISL1 mRNA]; Inositol promotes the reaction [Folic Acid inhibits the reaction [Homocysteine affects the expression of ISL1 mRNA]] |
CTD |
PMID:19638421 |
|
NCBI chr13:116,434,806...116,446,224
Ensembl chr13:116,434,817...116,446,225
|
|
G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor 1 |
multiple interactions increases expression |
ISO |
Homocysteine promotes the reaction [HSPA9 protein binds to ITPR1 protein] Homocysteine results in increased expression of ITPR1 protein |
CTD |
PMID:33751715 |
|
NCBI chr 6:108,190,044...108,528,077
Ensembl chr 6:108,190,057...108,528,070
|
|
G |
Keap1 |
kelch-like ECH-associated protein 1 |
increases expression |
ISO |
Homocysteine results in increased expression of KEAP1 protein |
CTD |
PMID:22964297 |
|
NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions increases phosphorylation |
ISO EXP |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; [1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Genistein] inhibits the reaction [Thapsigargin promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]]; Acetylcysteine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Folic Acid inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; fulvic acid inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Genistein inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Genistein inhibits the reaction [Thapsigargin promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]]; Go 6976 inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Pertussis Toxin inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Phorbol 12,13-Dibutyrate inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Phorbol 12,13-Dibutyrate promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Staurosporine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Tetradecanoylphorbol Acetate promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Thapsigargin promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; alpha-methyl-4-carboxyphenylglycine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Cystine affects the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Dizocilpine Maleate inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; RTKI cpd inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:16251475 PMID:19850060 PMID:25888188 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk14 |
mitogen-activated protein kinase 14 |
multiple interactions increases phosphorylation |
ISO EXP |
Acetylcysteine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK14 protein]; Atorvastatin inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK14 protein]; diphenyleneiodonium inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK14 protein]; NOX4 mutant form inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK14 protein]; SB 203580 inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK14 protein] |
CTD |
PMID:19767766 PMID:20018284 PMID:20305681 |
|
NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO EXP |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; [1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Genistein] inhibits the reaction [Thapsigargin promotes the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]]; Acetylcysteine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Folic Acid inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; fulvic acid inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Genistein inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Genistein inhibits the reaction [Thapsigargin promotes the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]]; Go 6976 inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Pertussis Toxin inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Phorbol 12,13-Dibutyrate inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Phorbol 12,13-Dibutyrate promotes the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Staurosporine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Tetradecanoylphorbol Acetate promotes the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Thapsigargin promotes the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein] 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; alpha-methyl-4-carboxyphenylglycine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Cystine affects the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Dizocilpine Maleate inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; RTKI cpd inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:16251475 PMID:19850060 PMID:25888188 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases phosphorylation multiple interactions |
ISO |
Homocysteine results in increased phosphorylation of MAPK8 protein fulvic acid inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:25888188 |
|
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
increases phosphorylation multiple interactions |
ISO |
Homocysteine results in increased phosphorylation of MAPK9 protein fulvic acid inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK9 protein] |
CTD |
PMID:25888188 |
|
NCBI chr11:49,737,558...49,777,248
Ensembl chr11:49,737,578...49,777,248
|
|
G |
Mcu |
mitochondrial calcium uniporter |
increases expression |
ISO |
Homocysteine results in increased expression of MCU protein |
CTD |
PMID:33751715 |
|
NCBI chr10:59,282,806...59,453,231
Ensembl chr10:59,282,806...59,452,514
|
|
G |
Mecp2 |
methyl CpG binding protein 2 |
multiple interactions |
ISO |
Homocysteine inhibits the reaction [MECP2 protein binds to CCNA1 promoter] |
CTD |
PMID:17698632 |
|
NCBI chr X:73,070,198...73,129,296
Ensembl chr X:73,070,198...73,129,296
|
|
G |
Mfn2 |
mitofusin 2 |
decreases expression |
ISO |
Homocysteine results in decreased expression of MFN2 protein |
CTD |
PMID:33751715 |
|
NCBI chr 4:147,958,043...147,989,527
Ensembl chr 4:147,958,056...147,989,161
|
|
G |
Mmp1b |
matrix metallopeptidase 1b (interstitial collagenase) |
multiple interactions |
ISO |
Dizocilpine Maleate inhibits the reaction [Homocysteine analog results in decreased expression of and results in decreased activity of MMP1 protein]; Homocysteine analog results in decreased expression of and results in decreased activity of MMP1 protein |
CTD |
PMID:20406136 |
|
NCBI chr 9:7,367,670...7,388,026
Ensembl chr 9:7,368,239...7,388,047
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression increases expression increases activity |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Homocysteine results in increased activity of MMP9 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Homocysteine results in increased expression of MMP9 protein]; Acetylcysteine inhibits the reaction [Homocysteine results in increased activity of MMP9 protein]; Acetylcysteine inhibits the reaction [Homocysteine results in increased expression of MMP9 protein]; Staurosporine inhibits the reaction [Homocysteine results in increased activity of MMP9 protein]; Staurosporine inhibits the reaction [Homocysteine results in increased expression of MMP9 protein] Dizocilpine Maleate inhibits the reaction [Homocysteine analog results in decreased expression of MMP9 protein] Homocysteine results in increased activity of and results in increased expression of MMP9 protein |
CTD |
PMID:16251475 PMID:20406136 PMID:22326992 |
|
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
increases expression multiple interactions affects abundance decreases methylation increases abundance affects metabolic processing |
ISO EXP |
Homocysteine results in increased expression of MTHFR protein [MTHFR gene mutant form co-treated with Methotrexate] results in increased abundance of Homocysteine MTHFR protein affects the abundance of Homocysteine metabolite Homocysteine inhibits the reaction [Simvastatin results in increased expression of MTHFR protein modified form]; Simvastatin promotes the reaction [Homocysteine results in increased expression of MTHFR protein] MTHFR protein SNP results in decreased methylation of Homocysteine MTHFR gene polymorphism results in increased abundance of Homocysteine; MTHFR protein mutant form results in increased abundance of Homocysteine MTHFR protein affects the metabolism of Homocysteine |
CTD |
PMID:7647779 PMID:17387702 PMID:18540024 PMID:19204075 PMID:19593106 PMID:19646848 PMID:20547447 More...
|
|
NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
|
|
G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
affects metabolic processing multiple interactions affects binding |
ISO |
MTR gene polymorphism affects the metabolism of Homocysteine Homocysteine inhibits the reaction [Folic Acid results in increased activity of MTR protein] Homocysteine binds to MTR protein |
CTD |
PMID:17477549 PMID:20532609 PMID:31721048 |
|
NCBI chr13:12,196,217...12,273,090
Ensembl chr13:12,197,598...12,272,999
|
|
G |
Mtrr |
5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
affects abundance |
EXP |
MTRR protein affects the abundance of Homocysteine |
CTD |
PMID:17369066 |
|
NCBI chr13:68,708,897...68,730,273
Ensembl chr13:68,708,899...68,730,268
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
affects localization increases phosphorylation multiple interactions |
ISO EXP |
Homocysteine affects the localization of NCF1 protein Homocysteine results in increased phosphorylation of NCF1 protein Filipin inhibits the reaction [Homocysteine affects the localization of NCF1 protein]; methyl-beta-cyclodextrin inhibits the reaction [Homocysteine affects the localization of NCF1 protein] Folic Acid inhibits the reaction [Homocysteine results in increased phosphorylation of NCF1 protein]; Homocysteine promotes the reaction [NCF1 protein results in increased abundance of Reactive Oxygen Species]; Homocysteine results in increased localization of and results in increased activity of NCF1 protein |
CTD |
PMID:16845898 PMID:17586618 PMID:20036696 |
|
NCBI chr 5:134,248,907...134,258,479
Ensembl chr 5:134,248,907...134,258,479
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
affects localization multiple interactions increases expression |
ISO EXP |
Homocysteine affects the localization of NFE2L2 protein modified form acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Homocysteine results in decreased expression of NFE2L2 protein]; Homocysteine results in decreased phosphorylation of and results in decreased expression of NFE2L2 protein; L 709049 inhibits the reaction [Homocysteine results in decreased expression of NFE2L2 protein]; N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal inhibits the reaction [Homocysteine results in decreased phosphorylation of and results in decreased expression of NFE2L2 protein] benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Homocysteine results in decreased phosphorylation of and results in decreased expression of NFE2L2 protein]; Homocysteine results in decreased phosphorylation of and results in decreased expression of NFE2L2 protein Homocysteine results in increased expression of NFE2L2 mRNA |
CTD |
PMID:22964297 |
|
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
|
|
G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
multiple interactions increases degradation |
ISO |
[Adenosine co-treated with Homocysteine] affects the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]; [Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA]; [Adenosine co-treated with Homocysteine] results in decreased expression of NFKBIA mRNA; [Homocysteine results in increased expression of CCL2 protein] which results in increased phosphorylation of NFKBIA protein; [Homocysteine results in increased expression of CCL2 protein] which results in increased reduction of NFKBIA mRNA; acetovanillone inhibits the reaction [Homocysteine results in increased phosphorylation of and results in increased activity of NFKBIA protein]; Folic Acid inhibits the reaction [Homocysteine results in increased phosphorylation of and results in increased activity of NFKBIA protein]; Homocysteine results in increased phosphorylation of and results in increased activity of NFKBIA protein Homocysteine results in increased degradation of NFKBIA protein |
CTD |
PMID:11356643 PMID:16845898 PMID:17586618 PMID:24224954 |
|
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
|
|
G |
Nfkbib |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, beta |
increases degradation |
ISO |
Homocysteine results in increased degradation of NFKBIB protein |
CTD |
PMID:17586618 |
|
NCBI chr 7:28,457,676...28,466,069
Ensembl chr 7:28,457,676...28,466,937
|
|
G |
Nkx2-5 |
NK2 homeobox 5 |
multiple interactions decreases expression |
ISO |
Particulate Matter promotes the reaction [Homocysteine results in decreased expression of NKX2-5 protein] Homocysteine results in decreased expression of NKX2-5 mRNA; Homocysteine results in decreased expression of NKX2-5 protein |
CTD |
PMID:27203204 |
|
NCBI chr17:27,057,638...27,063,962
Ensembl chr17:27,057,638...27,063,983
|
|
G |
Nlrc3 |
NLR family, CARD domain containing 3 |
multiple interactions increases expression |
EXP |
[Folic Acid deficiency results in increased abundance of Homocysteine] promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]; CASP1 protein affects the reaction [Homocysteine promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]]; Homocysteine promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]; PYCARD protein affects the reaction [Homocysteine promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]] Homocysteine results in increased expression of NLRC3 mRNA |
CTD |
PMID:22647887 |
|
NCBI chr16:3,762,871...3,796,881
Ensembl chr16:3,762,871...3,794,496
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
increases methylation increases expression multiple interactions |
ISO EXP |
Homocysteine results in increased methylation of NOS2 promoter Homocysteine results in increased expression of NOS2 mRNA Homocysteine affects the reaction [Simvastatin results in increased expression of NOS2 protein]; Simvastatin promotes the reaction [Homocysteine results in increased expression of NOS2 mRNA] [Homocysteine results in increased methylation of NOS2 promoter] which results in decreased expression of NOS2 mRNA; Clofibrate inhibits the reaction [Homocysteine results in increased methylation of NOS2 promoter]; pioglitazone inhibits the reaction [Homocysteine results in increased methylation of NOS2 promoter] |
CTD |
PMID:17492134 PMID:18540024 |
|
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
multiple interactions decreases expression decreases phosphorylation |
ISO EXP |
Folic Acid inhibits the reaction [Homocysteine results in decreased expression of and results in decreased activity of NOS3 protein]; Homocysteine results in decreased expression of and results in decreased activity of NOS3 protein; Zeranol inhibits the reaction [Homocysteine results in decreased expression of NOS3 protein] Homocysteine results in decreased expression of NOS3 mRNA; Homocysteine results in decreased expression of NOS3 protein Homocysteine results in decreased phosphorylation of NOS3 protein Atorvastatin inhibits the reaction [Homocysteine results in decreased expression of NOS3 mRNA]; Atorvastatin inhibits the reaction [Homocysteine results in decreased phosphorylation of NOS3 protein] |
CTD |
PMID:16757814 PMID:17357445 PMID:20305681 |
|
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
|
|
G |
Nox4 |
NADPH oxidase 4 |
multiple interactions increases response to substance increases expression |
ISO |
Atorvastatin inhibits the reaction [Homocysteine results in increased expression of NOX4 mRNA]; NOX4 mutant form inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK14 protein] NOX4 results in increased susceptibility to Homocysteine |
CTD |
PMID:20018284 |
|
NCBI chr 7:86,893,638...87,047,918
Ensembl chr 7:86,895,304...87,047,918
|
|
G |
Nphs2 |
nephrosis 2, podocin |
multiple interactions decreases expression |
EXP |
[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of NPHS2 mRNA; acetovanillone inhibits the reaction [Homocysteine results in decreased expression of NPHS2 mRNA]; acetovanillone inhibits the reaction [Homocysteine results in decreased expression of NPHS2 protein]; Amitriptyline inhibits the reaction [Homocysteine results in decreased expression of NPHS2 protein]; CYBB protein mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of NPHS2 mRNA]; diphenyleneiodonium inhibits the reaction [Homocysteine results in decreased expression of NPHS2 mRNA]; diphenyleneiodonium inhibits the reaction [Homocysteine results in decreased expression of NPHS2 protein]; Filipin inhibits the reaction [Homocysteine results in decreased expression of NPHS2 mRNA]; Filipin inhibits the reaction [Homocysteine results in decreased expression of NPHS2 protein]; methyl-beta-cyclodextrin inhibits the reaction [Homocysteine results in decreased expression of NPHS2 mRNA]; methyl-beta-cyclodextrin inhibits the reaction [Homocysteine results in decreased expression of NPHS2 protein] Homocysteine results in decreased expression of NPHS2 mRNA; Homocysteine results in decreased expression of NPHS2 protein |
CTD |
PMID:20036696 PMID:20116427 PMID:23024785 |
|
NCBI chr 1:156,138,105...156,155,605
Ensembl chr 1:156,138,297...156,155,605
|
|
G |
Nt5e |
5' nucleotidase, ecto |
affects activity |
EXP |
Homocysteine affects the activity of NT5E protein |
CTD |
PMID:24055814 |
|
NCBI chr 9:88,209,662...88,254,142
Ensembl chr 9:88,209,250...88,254,145
|
|
G |
Pacs2 |
phosphofurin acidic cluster sorting protein 2 |
increases expression |
ISO |
Homocysteine results in increased expression of PACS2 protein |
CTD |
PMID:33751715 |
|
NCBI chr12:112,977,998...113,038,021
Ensembl chr12:112,978,128...113,038,021
|
|
G |
Pon1 |
paraoxonase 1 |
multiple interactions |
EXP |
[Methionine results in increased abundance of Homocysteine] which results in decreased activity of PON1 protein; [resveratrol results in increased abundance of Homocysteine] which results in decreased activity of PON1 protein |
CTD |
PMID:19028542 |
|
NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946
|
|
G |
Prdx6 |
peroxiredoxin 6 |
multiple interactions |
ISO |
[Methionine deficiency co-treated with Homocysteine] affects the expression of PRDX6 protein |
CTD |
PMID:17116298 |
|
NCBI chr 1:161,067,682...161,078,780
Ensembl chr 1:161,067,682...161,078,789
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Homocysteine results in increased expression of PTGS2 mRNA]; fulvic acid inhibits the reaction [Homocysteine promotes the reaction [RELA protein binds to PTGS2 promoter]]; fulvic acid inhibits the reaction [Homocysteine results in increased expression of PTGS2 mRNA]; Homocysteine promotes the reaction [RELA protein binds to PTGS2 promoter]; pyrazolanthrone inhibits the reaction [Homocysteine results in increased expression of PTGS2 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Homocysteine results in increased expression of PTGS2 mRNA]; SN50 peptide inhibits the reaction [Homocysteine results in increased expression of PTGS2 mRNA] |
CTD |
PMID:25888188 |
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Pycard |
PYD and CARD domain containing |
multiple interactions increases expression |
EXP |
[Folic Acid deficiency results in increased abundance of Homocysteine] promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]; CASP1 protein affects the reaction [Homocysteine promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]]; Homocysteine promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]; PYCARD protein affects the reaction [Homocysteine promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]]; PYCARD protein affects the reaction [Homocysteine results in decreased secretion of VEGFA protein]; PYCARD protein affects the reaction [Homocysteine results in increased activity of CASP1 protein] Homocysteine results in increased expression of PYCARD mRNA |
CTD |
PMID:22647887 |
|
NCBI chr 7:127,590,545...127,593,039
Ensembl chr 7:127,588,880...127,593,039
|
|
G |
Rab1b |
RAB1B, member RAS oncogene family |
multiple interactions |
ISO |
[Methionine deficiency co-treated with Homocysteine] affects the expression of RAB1B protein |
CTD |
PMID:17116298 |
|
NCBI chr19:5,149,235...5,157,024
Ensembl chr19:5,149,233...5,157,100
|
|
G |
Rab9 |
RAB9, member RAS oncogene family |
multiple interactions |
ISO |
[Methionine deficiency co-treated with Homocysteine] affects the expression of RAB9A protein |
CTD |
PMID:17116298 |
|
NCBI chr X:165,240,247...165,262,863
Ensembl chr X:165,240,249...165,262,863
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions increases expression increases localization increases activity |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Homocysteine results in increased activity of RELA protein]; [Adenosine co-treated with Homocysteine] affects the reaction [TNF protein affects the localization of RELA protein modified form]; [Adenosine co-treated with Homocysteine] affects the reaction [TNF protein results in increased phosphorylation of RELA protein]; fulvic acid inhibits the reaction [Homocysteine promotes the reaction [RELA protein binds to PTGS2 promoter]]; Homocysteine promotes the reaction [RELA protein binds to PTGS2 promoter]; pyrazolanthrone inhibits the reaction [Homocysteine results in increased activity of RELA protein] Homocysteine results in increased expression of RELA protein Homocysteine inhibits the reaction [Simvastatin results in decreased expression of RELA protein] Homocysteine results in increased localization of RELA protein |
CTD |
PMID:17586618 PMID:18540024 PMID:24224954 PMID:25888188 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Ripk1 |
receptor (TNFRSF)-interacting serine-threonine kinase 1 |
multiple interactions |
ISO |
[Adenosine co-treated with Homocysteine co-treated with TNF protein] results in increased cleavage of RIPK1 protein |
CTD |
PMID:24224954 |
|
NCBI chr13:34,181,072...34,219,153
Ensembl chr13:34,186,346...34,221,130
|
|
G |
S100a4 |
S100 calcium binding protein A4 |
multiple interactions increases expression |
EXP |
[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of S100A4 mRNA; [Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of S100A4 protein; acetovanillone inhibits the reaction [Homocysteine results in increased expression of S100A4 protein]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of S100A4 mRNA]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of S100A4 protein]; CYBB mutant form inhibits the reaction [Homocysteine results in increased expression of S100A4 protein] Homocysteine results in increased expression of S100A4 mRNA; Homocysteine results in increased expression of S100A4 protein |
CTD |
PMID:21647593 |
|
NCBI chr 3:90,511,077...90,513,349
Ensembl chr 3:90,511,078...90,513,352
|
|
G |
Slc46a1 |
solute carrier family 46, member 1 |
affects abundance |
EXP |
SLC46A1 protein affects the abundance of Homocysteine metabolite |
CTD |
PMID:19204075 |
|
NCBI chr11:78,356,527...78,362,771
Ensembl chr11:78,356,523...78,362,885
|
|
G |
Sod1 |
superoxide dismutase 1, soluble |
increases expression |
ISO |
Homocysteine results in increased expression of SOD1 protein |
CTD |
PMID:17485853 |
|
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
|
|
G |
Sod2 |
superoxide dismutase 2, mitochondrial |
multiple interactions |
ISO |
[SOD2 gene SNP results in increased susceptibility to [Air Pollutants results in increased abundance of Particulate Matter]] which results in increased abundance of Homocysteine |
CTD |
PMID:30477822 |
|
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
|
|
G |
Ssr4 |
signal sequence receptor, delta |
multiple interactions |
ISO |
[Methionine deficiency co-treated with Homocysteine] affects the expression of SSR4 protein |
CTD |
PMID:17116298 |
|
NCBI chr X:72,830,778...72,834,432
Ensembl chr X:72,830,634...72,834,436
|
|
G |
Timp1 |
tissue inhibitor of metalloproteinase 1 |
multiple interactions increases expression |
ISO |
Dizocilpine Maleate inhibits the reaction [Homocysteine analog results in increased expression of TIMP1 mRNA]; Dizocilpine Maleate inhibits the reaction [Homocysteine analog results in increased expression of TIMP1 protein] Homocysteine analog results in increased expression of TIMP1 mRNA; Homocysteine analog results in increased expression of TIMP1 protein |
CTD |
PMID:20406136 |
|
NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974
|
|
G |
Tjp1 |
tight junction protein 1 |
multiple interactions decreases expression |
EXP |
[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of TJP1 mRNA; acetovanillone inhibits the reaction [Homocysteine results in decreased expression of TJP1 protein]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of TJP1 mRNA]; CYBB mutant form inhibits the reaction [Homocysteine results in decreased expression of TJP1 protein] Homocysteine results in decreased expression of TJP1 mRNA; Homocysteine results in decreased expression of TJP1 protein |
CTD |
PMID:21647593 |
|
NCBI chr 7:64,945,913...65,177,629
Ensembl chr 7:64,945,913...65,177,529
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO |
[Adenosine co-treated with Homocysteine co-treated with TNF protein] results in increased cleavage of RIPK1 protein; [Adenosine co-treated with Homocysteine] affects the reaction [TNF protein affects the localization of RELA protein modified form]; [Adenosine co-treated with Homocysteine] affects the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]; [Adenosine co-treated with Homocysteine] affects the reaction [TNF protein results in increased phosphorylation of RELA protein]; [Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; [Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA]; [Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of TNFAIP3 mRNA]; [Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of TNFAIP3 protein]; [Adenosine co-treated with Homocysteine] results in increased susceptibility to TNF protein Homocysteine results in increased expression of TNF protein |
CTD |
PMID:24224954 PMID:27203204 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfaip3 |
tumor necrosis factor, alpha-induced protein 3 |
multiple interactions |
ISO |
[Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of TNFAIP3 mRNA]; [Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of TNFAIP3 protein]; [Adenosine co-treated with Homocysteine] results in decreased expression of TNFAIP3 mRNA; [Adenosine co-treated with Homocysteine] results in decreased expression of TNFAIP3 protein |
CTD |
PMID:24224954 |
|
NCBI chr10:18,876,658...18,891,158
Ensembl chr10:18,876,658...18,891,405
|
|
G |
Trp53 |
transformation related protein 53 |
increases phosphorylation affects expression multiple interactions |
ISO |
Homocysteine results in increased phosphorylation of TP53 protein Homocysteine affects the expression of TP53 mRNA; Homocysteine affects the expression of TP53 protein Folic Acid affects the reaction [Homocysteine affects the expression of TP53 mRNA]; Folic Acid affects the reaction [Homocysteine affects the expression of TP53 protein] |
CTD |
PMID:13679428 PMID:29250709 |
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Vbp1 |
von Hippel-Lindau binding protein 1 |
multiple interactions |
ISO |
[Methionine deficiency co-treated with Homocysteine] affects the expression of VBP1 protein |
CTD |
PMID:17116298 |
|
NCBI chr X:74,557,903...74,578,552
Ensembl chr X:74,557,905...74,578,548
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions increases expression |
ISO |
3,4-dihydroxyphenylethanol inhibits the reaction [Homocysteine results in increased expression of VCAM1 protein]; resveratrol inhibits the reaction [Homocysteine results in increased expression of VCAM1 protein] Homocysteine results in increased expression of VCAM1 mRNA; Homocysteine results in increased expression of VCAM1 protein |
CTD |
PMID:17586618 |
|
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
|
|
G |
Vdac1 |
voltage-dependent anion channel 1 |
increases expression multiple interactions |
ISO |
Homocysteine results in increased expression of VDAC1 protein Homocysteine promotes the reaction [HSPA9 protein binds to VDAC1 protein] |
CTD |
PMID:33751715 |
|
NCBI chr11:52,251,905...52,280,224
Ensembl chr11:52,251,687...52,280,224
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions increases expression decreases expression decreases secretion |
EXP ISO |
Amitriptyline inhibits the reaction [Homocysteine results in decreased secretion of VEGFA protein]; CASP1 protein affects the reaction [Homocysteine results in decreased secretion of VEGFA protein]; CYBB protein affects the reaction [Homocysteine results in decreased secretion of VEGFA protein]; diphenyleneiodonium inhibits the reaction [Homocysteine results in decreased secretion of VEGFA protein]; Homocysteine results in decreased expression of and results in decreased secretion of VEGFA protein; PYCARD protein affects the reaction [Homocysteine results in decreased secretion of VEGFA protein] Homocysteine results in increased expression of VEGFA protein Homocysteine results in decreased expression of VEGFA mRNA |
CTD |
PMID:17485853 PMID:20116427 PMID:22647887 PMID:23024785 |
|
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
|
|
G |
Vim |
vimentin |
increases expression |
ISO |
Homocysteine results in increased expression of VIM protein |
CTD |
PMID:17485853 |
|
NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637
|
|
G |
Vps29 |
VPS29 retromer complex component |
multiple interactions |
ISO |
[Methionine deficiency co-treated with Homocysteine] affects the expression of VPS29 protein |
CTD |
PMID:17116298 |
|
NCBI chr 5:122,492,391...122,503,047
Ensembl chr 5:122,492,432...122,503,047
|
|
G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
decreases expression |
ISO |
Homocysteine results in decreased expression of WNT5A mRNA |
CTD |
PMID:17320366 |
|
NCBI chr14:28,224,962...28,249,405
Ensembl chr14:28,226,707...28,249,405
|
|
G |
Xbp1 |
X-box binding protein 1 |
multiple interactions decreases expression increases expression increases splicing |
ISO |
Glycine affects the reaction [Homocysteine results in increased splicing of XBP1 mRNA] Homocysteine results in decreased expression of XBP1 protein Homocysteine results in increased expression of XBP1 mRNA alternative form |
CTD |
PMID:19960509 PMID:22964297 PMID:27064126 |
|
NCBI chr11:5,470,641...5,475,993
Ensembl chr11:5,470,659...5,475,893
|
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
multiple interactions |
ISO |
[homocysteic acid co-treated with GW 506033X] results in increased phosphorylation of EIF2S1 protein |
CTD |
PMID:19046382 |
|
NCBI chr12:78,908,846...78,933,784
Ensembl chr12:78,908,593...78,933,784
|
|
G |
Hsf1 |
heat shock factor 1 |
decreases expression |
ISO |
homocysteic acid results in decreased expression of HSF1 protein |
CTD |
PMID:24478344 |
|
NCBI chr15:76,361,562...76,385,355
Ensembl chr15:76,361,622...76,386,113
|
|
G |
Sp1 |
trans-acting transcription factor 1 |
increases activity multiple interactions |
ISO |
homocysteic acid results in increased activity of SP1 protein mithramycin A inhibits the reaction [homocysteic acid results in increased activity of SP1 protein] |
CTD |
PMID:11261509 |
|
NCBI chr15:102,314,751...102,344,839
Ensembl chr15:102,314,578...102,344,839
|
|
G |
Sp3 |
trans-acting transcription factor 3 |
multiple interactions increases activity |
ISO |
mithramycin A inhibits the reaction [homocysteic acid results in increased activity of SP3 protein] |
CTD |
PMID:11261509 |
|
NCBI chr 2:72,766,774...72,810,790
Ensembl chr 2:72,766,771...72,810,790
|
|
|
G |
Ahcy |
S-adenosylhomocysteine hydrolase |
increases hydrolysis |
ISO |
AHCY results in increased hydrolysis of S-Adenosylhomocysteine |
CTD |
PMID:26974671 |
|
NCBI chr 2:154,901,230...154,916,417
Ensembl chr 2:154,901,230...154,916,417
|
|
G |
Ahr |
aryl-hydrocarbon receptor |
multiple interactions increases abundance |
EXP |
PEMT protein promotes the reaction [AHR protein results in increased abundance of S-Adenosylhomocysteine] |
CTD |
PMID:29416063 |
|
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
|
|
G |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
multiple interactions |
ISO |
[S-Adenosylhomocysteine co-treated with Hemin] results in increased expression of ALAS2 mRNA; catechol inhibits the reaction [[S-Adenosylhomocysteine co-treated with Hemin] results in increased expression of ALAS2 mRNA] |
CTD |
PMID:24141029 |
|
NCBI chr X:149,330,443...149,353,614
Ensembl chr X:149,330,371...149,353,634
|
|
G |
App |
amyloid beta precursor protein |
increases expression decreases methylation multiple interactions |
EXP |
S-Adenosylhomocysteine results in increased expression of APP protein S-Adenosylhomocysteine results in decreased methylation of APP promoter Betaine inhibits the reaction [S-Adenosylhomocysteine results in decreased methylation of APP promoter]; Betaine inhibits the reaction [S-Adenosylhomocysteine results in increased expression of and results in increased cleavage of APP protein]; S-Adenosylhomocysteine results in increased expression of and results in increased cleavage of APP protein |
CTD |
PMID:19635394 PMID:22064374 |
|
NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
|
|
G |
Atp7b |
ATPase, Cu++ transporting, beta polypeptide |
increases abundance |
EXP |
ATP7B protein mutant form results in increased abundance of S-Adenosylhomocysteine |
CTD |
PMID:22945834 |
|
NCBI chr 8:22,482,799...22,550,347
Ensembl chr 8:22,482,801...22,550,321
|
|
G |
Bace1 |
beta-site APP cleaving enzyme 1 |
increases expression |
EXP |
S-Adenosylhomocysteine results in increased expression of BACE1 protein |
CTD |
PMID:19635394 |
|
NCBI chr 9:45,749,878...45,775,694
Ensembl chr 9:45,749,878...45,775,697
|
|
G |
Carm1 |
coactivator-associated arginine methyltransferase 1 |
decreases activity |
ISO |
S-Adenosylhomocysteine results in decreased activity of CARM1 protein |
CTD |
PMID:33577917 |
|
NCBI chr 9:21,458,163...21,500,763
Ensembl chr 9:21,458,190...21,503,919
|
|
G |
Col1a1 |
collagen, type I, alpha 1 |
decreases expression |
ISO |
S-Adenosylhomocysteine results in decreased expression of COL1A1 mRNA |
CTD |
PMID:15983038 |
|
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
|
|
G |
Col1a2 |
collagen, type I, alpha 2 |
decreases expression |
ISO |
S-Adenosylhomocysteine results in decreased expression of COL1A2 mRNA |
CTD |
PMID:15983038 |
|
NCBI chr 6:4,505,618...4,541,543
Ensembl chr 6:4,504,814...4,541,544
|
|
G |
Comt |
catechol-O-methyltransferase |
decreases activity |
ISO |
S-Adenosylhomocysteine results in decreased activity of COMT protein |
CTD |
PMID:10064789 |
|
NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
decreases activity multiple interactions |
ISO EXP |
S-Adenosylhomocysteine results in decreased activity of DNMT1 protein S-Adenosylhomocysteine inhibits the reaction [DNMT1 protein binds to OGG1 promoter] |
CTD |
PMID:16037419 PMID:22064374 |
|
NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184
|
|
G |
Fgf15 |
fibroblast growth factor 15 |
decreases abundance |
EXP |
FGF19 protein results in decreased abundance of S-Adenosylhomocysteine |
CTD |
PMID:29416063 |
|
NCBI chr 7:144,450,269...144,454,690
Ensembl chr 7:144,450,268...144,454,690
|
|
G |
Hbb-b1 |
hemoglobin, beta adult major chain |
multiple interactions |
ISO |
[S-Adenosylhomocysteine co-treated with Hemin] results in increased expression of HBB mRNA; catechol inhibits the reaction [[S-Adenosylhomocysteine co-treated with Hemin] results in increased expression of HBB mRNA] |
CTD |
PMID:24141029 |
|
|
|
G |
Hmbs |
hydroxymethylbilane synthase |
multiple interactions |
ISO |
[S-Adenosylhomocysteine co-treated with Hemin] results in increased expression of HMBS mRNA; catechol inhibits the reaction [[S-Adenosylhomocysteine co-treated with Hemin] results in increased expression of HMBS mRNA] |
CTD |
PMID:24141029 |
|
NCBI chr 9:44,247,645...44,255,525
Ensembl chr 9:44,247,636...44,255,525
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
increases expression multiple interactions |
EXP ISO |
S-Adenosylhomocysteine results in increased expression of MMP2 mRNA; S-Adenosylhomocysteine results in increased expression of MMP2 protein S-Adenosylhomocysteine promotes the reaction [SP1 protein binds to MMP2 promoter] U 0126 inhibits the reaction [S-Adenosylhomocysteine results in increased expression of MMP2 protein] |
CTD |
PMID:19770485 |
|
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
|
|
G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
decreases expression |
ISO |
S-Adenosylhomocysteine results in decreased expression of NFKBIA protein |
CTD |
PMID:19770485 |
|
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
decreases abundance |
EXP |
NR0B2 protein results in decreased abundance of S-Adenosylhomocysteine |
CTD |
PMID:29416063 |
|
NCBI chr 4:133,280,687...133,283,997
Ensembl chr 4:133,280,687...133,283,847
|
|
G |
Ogg1 |
8-oxoguanine DNA-glycosylase 1 |
multiple interactions decreases methylation decreases expression |
EXP |
Betaine inhibits the reaction [S-Adenosylhomocysteine results in decreased expression of OGG1 protein]; Betaine inhibits the reaction [S-Adenosylhomocysteine results in decreased methylation of OGG1 promoter]; S-Adenosylhomocysteine inhibits the reaction [DNMT1 protein binds to OGG1 promoter] S-Adenosylhomocysteine results in decreased expression of OGG1 mRNA; S-Adenosylhomocysteine results in decreased expression of OGG1 protein |
CTD |
PMID:22064374 |
|
NCBI chr 6:113,303,959...113,311,149
Ensembl chr 6:113,303,933...113,312,029
|
|
G |
Pemt |
phosphatidylethanolamine N-methyltransferase |
multiple interactions |
EXP |
PEMT protein promotes the reaction [AHR protein results in increased abundance of S-Adenosylhomocysteine] |
CTD |
PMID:29416063 |
|
NCBI chr11:59,861,440...59,937,394
Ensembl chr11:59,861,440...59,937,315
|
|
G |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
increases expression |
ISO |
S-Adenosylhomocysteine results in increased expression of PPARGC1A mRNA |
CTD |
PMID:23056435 |
|
NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
|
|
G |
Prmt1 |
protein arginine N-methyltransferase 1 |
decreases activity |
ISO |
S-Adenosylhomocysteine results in decreased activity of PRMT1 protein |
CTD |
PMID:33577917 |
|
NCBI chr 7:44,626,179...44,635,844
Ensembl chr 7:44,625,413...44,635,992
|
|
G |
Prmt5 |
protein arginine N-methyltransferase 5 |
decreases activity |
ISO |
S-Adenosylhomocysteine results in decreased activity of PRMT5 protein |
CTD |
PMID:33577917 |
|
NCBI chr14:54,744,639...54,754,927
Ensembl chr14:54,744,644...54,754,982
|
|
G |
Prmt6 |
protein arginine N-methyltransferase 6 |
decreases activity |
ISO |
S-Adenosylhomocysteine results in decreased activity of PRMT6 protein |
CTD |
PMID:33577917 |
|
NCBI chr 3:110,153,420...110,158,315
Ensembl chr 3:110,153,425...110,158,314
|
|
G |
Prmt7 |
protein arginine N-methyltransferase 7 |
decreases activity |
ISO |
S-Adenosylhomocysteine results in decreased activity of PRMT7 protein |
CTD |
PMID:33577917 |
|
NCBI chr 8:106,937,686...106,978,326
Ensembl chr 8:106,937,568...106,979,426
|
|
G |
Psen1 |
presenilin 1 |
multiple interactions decreases methylation increases expression |
EXP |
Betaine inhibits the reaction [S-Adenosylhomocysteine results in decreased methylation of PSEN1 promoter] S-Adenosylhomocysteine results in increased expression of PSEN1 protein |
CTD |
PMID:19635394 |
|
NCBI chr12:83,734,926...83,781,869
Ensembl chr12:83,734,926...83,781,973
|
|
G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
affects abundance |
EXP |
SLC19A1 protein affects the abundance of S-Adenosylhomocysteine |
CTD |
PMID:15705887 |
|
NCBI chr10:76,868,103...76,886,266
Ensembl chr10:76,868,075...76,896,836
|
|
G |
Sp1 |
trans-acting transcription factor 1 |
multiple interactions |
ISO |
S-Adenosylhomocysteine promotes the reaction [SP1 protein binds to MMP2 promoter] |
CTD |
PMID:19770485 |
|
NCBI chr15:102,314,751...102,344,839
Ensembl chr15:102,314,578...102,344,839
|
|
G |
Timp2 |
tissue inhibitor of metalloproteinase 2 |
decreases expression |
EXP |
S-Adenosylhomocysteine results in decreased expression of TIMP2 protein |
CTD |
PMID:19770485 |
|
NCBI chr11:118,191,887...118,246,237
Ensembl chr11:118,191,887...118,246,566
|
|